Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography
This study has been completed.
Study NCT01561924
Information provided by Novo Nordisk
First Received on March 21, 2012.
Last Updated on June 15, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
